← FDA ENFORCEMENT
D-0392-2024Class II

Hikma Pharmaceuticals USA Inc.

Recalling firm
Hikma Pharmaceuticals USA Inc.
Product type
Drug
Status
Ongoing
Report date
2024-03-27
Distribution
Nationwide within the United States
Firm state
NJ
Product quantity
22,644 ampuls
Initiated by
Voluntary: Firm initiated
SPEQ quality domain
Validation & Qualification
Reason for recall

The filter included in the carton has an expiration date that has expired prior to the expiration date of the actual product lot.

Product description

Infumorph (Preservative-free Morphine Sulfate Sterile Solution), 20 mL ampul, Rx only, Manufactured by Hikma Berkeley Heights, NJ 07922, NDC 0641-6039-01

Code / lot info

Lot #: 052001, 052003, Exp. Date 11/2024; 023012, 023014, Exp. Date 08/2024

Other recalls SPEQ maps to Validation & Qualification
2026-07-22Class IIBell Pharmaceuticals, Inc2026-07-22Class IIBell Pharmaceuticals, Inc2026-07-22Class IIBell Pharmaceuticals, Inc2026-07-22Class IIBell Pharmaceuticals, Inc
See all Validation & Qualification recalls →

Data: U.S. FDA openFDA enforcement API. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification.